Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8949961 | Pathology - Research and Practice | 2018 | 17 Pages |
Abstract
TUSC3 may act as an oncogene in the progression of colorectal cancer. Moreover, TUSC3 has potential to be used as prognostic markers or therapeutic targets in CRC.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Yu Feng Zhu, Ming Dong,